Sino Biopharmaceutical Limited and its subsidiaries are the leading innovative research and R&D-driven pharmaceutical group in China, with a business scope that covers the full industry chain of pharmaceutical R&D platforms, intelligent production and strong sales systems. Its product offerings include a variety of biological drugs and chemical drugs, and it occupies an advantageous position in many potential therapeutic fields such as liver disease, tumors, cardiovascular and cerebrovascular diseases, orthopedics, digestive system, immune and respiratory diseases.
Looking for a particular Sino Biopharmaceutical Limited employee's phone or email?
The Sino Biopharmaceutical Limited annual revenue was $3.7 billion in 2026.
Alice Li is the CFO of Sino Biopharmaceutical Limited.
26 people are employed at Sino Biopharmaceutical Limited.
The NAICS codes for Sino Biopharmaceutical Limited are [5417, 54, 541711, 54171, 541, 33].
The SIC codes for Sino Biopharmaceutical Limited are [37, 376, 87, 873].